Picture of ReproCell logo

4978 ReproCell Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for ReproCell, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
2026
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoTanshin
Standards:
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-574-304-28.945.1-587
Depreciation
Amortisation
Non-Cash Items-14.327.1-265-92.5-184
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital282872463.05313
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-246-141-11.46.29-384
Capital Expenditures-43.4-150-171-86.7-98.2
Purchase of Fixed Assets
Other Investing Cash Flow Items-2,101-937576-709156
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-2,144-1,087404-79657.9
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2,385483544680
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash35.6-7221,024-116-220